This is a delivery order awarded by the Joint Program Executive Office for Chemical and Biological Defense, a component of the U.S. Department of Defense, to Biofire Defense LLC, a for-profit limited liability company. The $83,933 firm fixed price contract is for a commercial system upgrade for a product development phase. It is not associated with any set-aside program. Biofire Defense is a manufacturer of biological agent identification products, including the Biofire FilmArray and RAZOR Mk...
This is a $488,135 firm fixed price delivery order awarded by the Joint Program Executive Office for Chemical and Biological Defense to Biofire Defense LLC, a for-profit limited liability company. The award is for the delivery of the TD Phase Commercial System, with an ultimate completion date of June 29, 2017. Biofire Defense is the prime contractor and there is no set-aside designation for this award. The company has received past awards from the Department of Defense, Department of State,...
This firm fixed-price delivery order was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Biofire Defense LLC, a manufacturer of biological agent identification products. The $158,620.00 contract is for non-warranty film array repairs, with a completion date of January 21, 2022. Biofire Defense LLC is a for-profit limited liability company that has previously received prime and subcontract awards from the Department of Defense,...
This federal contract was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Biofire Defense LLC, a limited liability company that manufactures biological agent identification products. The $123,840 firm fixed price contract is for the delivery of a non-biological warfare agent in-vitro diagnostic (IVD) assay. The contract has no set-aside designation and was completed on February 28, 2018. Biofire Defense is a manufacturer of...
This federal contract award, HDTRA115P0014, was issued by the Defense Threat Reduction Agency (DTRA) to Biofire Defense LLC, a limited liability company that manufactures biological agent identification products. The purpose of the $120,349.40 firm fixed price contract is to obtain a Clinical Laboratory Improvement Amendments (CLIA) waiver for Biofire's FilmArray Biothreat Detection System, increasing access to this easy-to-use system for the warfighter. The contract has no set-aside...
This is a delivery order awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The $271,232.89 firm fixed-price contract is for PD phase operational BWA environmental A/Warrior and Sentinel panels, with a performance period from May 1, 2019 to July 1, 2019. Biofire Defense has a history of providing diagnostic assays,...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $183,215.81 firm fixed-price delivery order contract to Biofire Defense LLC, a for-profit limited liability company and manufacturer of goods, for the delivery of sentinel panels. The contract has a completion date of November 28, 2022 and is not set aside. Biofire Defense LLC is a provider of biological agent identification products, including the Biofire FilmArray and RAZOR Mk II...
This is a firm fixed-price purchase order awarded by the Defense Advanced Research Projects Agency (DARPA) to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract, valued at $85,985.35, is for the delivery of WRAIR_BIOFIRE FILM ARRAY goods and services. Biofire Defense has previously received prime and subcontract awards from various federal agencies for biological threat detection, infectious disease testing, and...
This is a federal contract award to Biofire Defense LLC, a manufacturer of biological agent identification products, by the Joint PEO Chemical and Biological Defense, a Defense agency. The $98,595.30 cost-plus-fixed-fee delivery order is for engineering studies and does not have a set-aside designation. Biofire Defense has received prior prime and subcontract awards from the Department of Defense, Department of State, National Institutes of Health, and Department of Health and Human Services...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $245,965.19 firm fixed price delivery order to Biofire Defense LLC, a for-profit limited liability company, for software security updates. This award is part of a larger indefinite delivery contract the Army has with Biofire Defense for sustainment of the Next Generation Diagnostic System, with a potential value of $18.8 million through January 2029. The contract does not have a set-aside...